⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Meghan TownsendDO

Hematology-Oncology · Richmond, VA 23298

NPI: 1477087732

Share:

39

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingElevated long-acting opioid rate

Risk indicators are statistical patterns, not allegations. Learn more

394

Total Claims

$24K

Drug Cost

76

Beneficiaries

$316

Cost/Patient

Risk Score Breakdown 39/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
Long-acting opioid rate+4

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+790%

Opioid rate vs peers

55.8% vs 6.3% avg

-98%

Cost per patient vs peers

$316 vs $14K avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 790% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

55.8%

Opioid Rate

220

Opioid Claims

$16K

Opioid Cost

35.0%

Long-Acting Rate

This provider's opioid prescribing rate of 55.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 356 claims · $15K

Patient Profile

68

Avg Age

47%

Female

3.62

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About